Retatrutide is an investigational triple agonist targeting GLP-1, glucagon, and GIP receptors designed to improve glycemic control in patients with type 2 diabetes and to support weight management. As… Read more
Retatrutide is an investigational triple agonist targeting GLP-1, glucagon, and GIP receptors designed to improve glycemic control in patients with type 2 diabetes and to support weight management. As this peptide hormone analog undergoes clinical development, high-quality analytical support is essential for characterizing the drug substance and its metabolic profile. This category provides essential reference standards, including the active pharmaceutical ingredient, identified process-related impurities, and degradation products for impurity profiling. Additionally, stable isotope labelled compounds are available to serve as reliable internal standards for mass spectrometry-based assays. These materials are critical for pharmaceutical laboratories performing rigorous quality control, method development, and validation to ensure the purity and stability of the compound throughout the drug development lifecycle.